Scholarlink

<p>Eustachian tube dysfunction (ETD) poses challenges due to its multifaceted impact on middle- ear system and auditory function. Balloon Eustachian tuboplasty (BET) emerges as a promising intervention for patients irresponsive to conventional therapies. This study evaluates the clinical outcomes of BET in 11 patients with recurrent, previously treated chronic ETD. Pre and post-operative assessments included Pure Tone Audiometry (PTA), Immittance Audiometry and modified Eustachian Tube Dysfunction Questionnaire (ETDQ-7). Scores were analysed retrospectively at 1, 6, and 12 months post-treatment. Significant results demonstrated with improvements in PTA average and ETDQ scores across the time period with notable functional gains observed in 9 out of 11 patients. The majority of subjects experienced maximal improvement within the first month post-operatively, emphasizing early efficacy. Two patients showed delayed but substantial improvement by the 6th and 12th months, respectively. Nasal sprays were adjunctively administered during the early recuberate period. Overall, bilateral BET proved effectiveness in alleviating symptoms and enhancing auditory function in patients with chronic, treatment-resistant ETD. This study supports BET as a feasible option in managing refractory ETD cases, highlighting the importance of early post-operative follow-up and accustomed therapeutic strategies for better patient quality of life.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Functional Outcome Measure Post Balloon Eustachian Tuboplasty in Aviation Professionals with Persistent Eustachian Tube Dysfunction- a Pilot Study

  • 期刊论文

  • 发表日期：

    2026年4月15日

查看全文
  • Sanjeev Mohanty,
  • Mohammed Eliyas,
  • Deepthi Padmanabhan,
  • Balaji Kumaragurubaran,
  • Guna Keerthana Ramesh,
  • Abhinaya Swaminathan

摘要

Eustachian tube dysfunction (ETD) poses challenges due to its multifaceted impact on middle- ear system and auditory function. Balloon Eustachian tuboplasty (BET) emerges as a promising intervention for patients irresponsive to conventional therapies. This study evaluates the clinical outcomes of BET in 11 patients with recurrent, previously treated chronic ETD. Pre and post-operative assessments included Pure Tone Audiometry (PTA), Immittance Audiometry and modified Eustachian Tube Dysfunction Questionnaire (ETDQ-7). Scores were analysed retrospectively at 1, 6, and 12 months post-treatment. Significant results demonstrated with improvements in PTA average and ETDQ scores across the time period with notable functional gains observed in 9 out of 11 patients. The majority of subjects experienced maximal improvement within the first month post-operatively, emphasizing early efficacy. Two patients showed delayed but substantial improvement by the 6th and 12th months, respectively. Nasal sprays were adjunctively administered during the early recuberate period. Overall, bilateral BET proved effectiveness in alleviating symptoms and enhancing auditory function in patients with chronic, treatment-resistant ETD. This study supports BET as a feasible option in managing refractory ETD cases, highlighting the importance of early post-operative follow-up and accustomed therapeutic strategies for better patient quality of life.